Abstract
Liver-specific gene therapy is advantageous to minimize the possible adverse effects caused by non-target gene expression. The CMV promoter of the enhanced green fluorescent protein (EGFP) expressing plasmid pCMV-EGFP was replaced with the liver-specific promoter apolipoprotein A-I (ApoAI) generating pApoAI-EGFP plasmid. In vitro expression experiments performed in various cell lines including HepG2, SMMC-7721, MCF7, ACC-2 and Lo2 indicated that pCMV-EGFP treatment caused gene expression in all the cell lines, whereas pApoAI-EGFP treatment only induced EGFP expression in cells of liver origin including the liver cancer cells HepG2 and SMMC-7721 and the normal liver cells Lo2. Either pCMV-EGFP or pApoAI-EGFP was formulated as pegylated immuno-lipopolyplexes (PILP), a novel and efficient gene delivery system. Following intravenous administration of the PILP in H22 tumor-bearing mice, there was significant EGFP expression in liver, tumor, spleen, brain and lung in the pCMV-EGFP treated mice, whereas in the pApoAI-EGFP treated mice there was only gene expression in liver and tumor and the non-liver organ gene expression was eliminated. This study suggests that the use of the PILP technology and liver-specific promoter enables effic...Continue Reading
References
Feb 1, 1991·Molecular and Cellular Biology·R L WidomS K Karathanasis
Feb 1, 1988·Molecular and Cellular Biology·K N SastryS K Karathanasis
Apr 12, 1994·Proceedings of the National Academy of Sciences of the United States of America·S H ChenS L Woo
Jun 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A P Venook
Mar 12, 1999·DNA and Cell Biology·D R Jones, M Leffak
Jan 26, 2000·Human Gene Therapy·B De GeestP Holvoet
Apr 21, 2001·Gene Therapy·B De GeestD Collen
Jul 27, 2001·Gene·Z L XuT Hayakawa
Oct 11, 2001·Proceedings of the National Academy of Sciences of the United States of America·N ShiW M Pardridge
Feb 8, 2003·Molecular Therapy : the Journal of the American Society of Gene Therapy·Yun ZhangWilliam M Pardridge
Jan 13, 2004·Methods in Enzymology·C Tros de IlarduyaN Düzgüneş
May 4, 2004·Annals of Medicine·Albert K GroenFolkert Kuipers
Oct 28, 2004·Gastroenterology·F Xavier BoschRamon Cléries
May 27, 2005·Seminars in Liver Disease·Lewis R Roberts, Gregory J Gores
Apr 13, 2007·Blood Cells, Molecules & Diseases·Alessia CalzolariUgo Testa
Mar 5, 2008·Archives of Biochemistry and Biophysics·Marina C GonzalezHoracio A Garda
Apr 11, 2008·Gene Therapy·E WisseB De Geest
Feb 11, 2010·Journal of Controlled Release : Official Journal of the Controlled Release Society·Yurong HuYun Zhang